Market revenue in 2023 | USD 91.6 million |
Market revenue in 2030 | USD 149.8 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | BD, Danaher Corp, Koninklijke Philips NV, Qiagen NV, Thermo Fisher Scientific Inc, Myriad Genetics Inc, Argon Medical Devices, Roche Holding AG ADR, Hologic Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 63.76% in 2023. Horizon Databook has segmented the South Africa breast cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The South African Government has also collaborated with the UNO to improve healthcare measures for decreasing mortality and increasing life expectancy. Owing to the aforementioned factors, the region is expected to witness positive growth in the breast cancer diagnostics market.
The average 5-year survival rate in Africa is 50%. High incidence of breast cancer is due to inadequate access to early detection and low awareness of the disease in the country. The government of South Africa has made basic healthcare reforms by providing free primary healthcare and diagnostic services to breast cancer patients.
Many multinational companies such as F. Hoffmann-La Roche and Hologic Inc. are showing interest in the South African market, forming joint ventures with local companies such as the Southern African Laboratory Diagnostics Association (SALDA). SALDA represents laboratory medicine in South Africa that distributes diagnostics tests in the country. Owing to the abovementioned factors, South Africa is expected to witness growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa breast cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Africa breast cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account